Clinical Trials Logo

Microscopic Colitis clinical trials

View clinical trials related to Microscopic Colitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03275467 Completed - Microscopic Colitis Clinical Trials

Faecal Microbiota Transplantation in Patients With Microscopic Colitis

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Microscopic colitis (MC) is a disease with chronic inflammation of the colon that is mostly diagnosed in middle-aged or elderly women. Patients suffer from chronic watery diarrhoea, abdominal pain and weight loss. The aetiology of MC is still unknown but it is hypothesized that MC is caused by a deregulated immune response to a luminal agent in predisposed individuals, and an important role of the intestinal microbiota is suggested. In the current proof-of-concept study, the effect of faecal microbiota transfer (FMT) in 10 MC patients will be evaluated. FMT consists in the infusion of suspended stool from a healthy donor into the intestine of a patient with the aim to restore a disturbed intestinal microbiota.

NCT ID: NCT02303132 Completed - Microscopic Colitis Clinical Trials

Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis

Start date: November 2015
Phase: N/A
Study type: Interventional

Medication use, especially NSAIDs and PPIs, prior to diagnosis is considered a risk factor for MC development. However, the exact pathophysiological mechanism is unclear. It is hypothesized that NSAIDs, PPIs, and SSRIs may have an effect on the colon permeability, due to an idiosyncratic reaction which results in a local immune response. MC patients are considered to be susceptible hosts, prone to react on administration of abovementioned drugs. In order to test this hypothesis and to generate new insights in the pathophysiology of MC, we want to perform an Ussing chamber experiment using fresh colon tissue samples. The primary objective is to assess ex vivo the effect of NSAIDs and PPIs on epithelial permeability of colon biopsy specimens of MC and non-MC patients, using the Ussing chamber system

NCT ID: NCT01928667 Completed - Microscopic Colitis Clinical Trials

Case-Control Study to Identify Risk Factors for Microscopic Colitis

Start date: July 2014
Phase: N/A
Study type: Observational

The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.

NCT ID: NCT00952952 Completed - Diarrhea Clinical Trials

Trial of Mesalamine for the Treatment of Active Microscopic Colitis

Start date: February 2007
Phase: Phase 2/Phase 3
Study type: Interventional

Subjects must be 18 years old and older, have diarrhea and microscopic colitis. Pregnant or nursing females are excluded. They can't have other untreated diarrheal conditions. Subjects will receive medication for 8 weeks, followed by sigmoidoscopy with biopsies. The subjects will be monitored weekly. A pathologist will review pre and post treatment biopsies. Subjects that show improvement will be followed for 4 weeks post medication.

NCT ID: NCT00180050 Completed - Microscopic Colitis Clinical Trials

Budesonide Treatment for Lymphocytic Colitis

Start date: January 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis